Last 12 months
Inside the activity.
16 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 0 |
| Dec 2025 | 3 | 0 |
| Jan 2026 | 3 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 2 | 0 |
| Apr 2026 | 1 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 1 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 03, 2023 Filed Apr 25, 2023 21:50 UTC |
Bolck Joachim Eberhard10% owner
|
PurchaseCommon Stock | 10,000 | $0.90 | $9,000.00 |
DisclosureSEC source: 0001753926-23-000518 · ownership.xml · nonDerivative · entry 2 Bolck Joachim Eberhard · CIK 0001974849 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 2,524,229 F1 · ownership.nature: Joachim and Yaeko Bolck as conservators for Hideo Saito Bolck. Read SEC document |
| December 27, 2022 Filed Apr 25, 2023 21:49 UTC |
Bolck Joachim Eberhard10% owner
|
PurchaseCommon Stock | 10,000 | $1.02 | $10,200.00 |
DisclosureSEC source: 0001753926-23-000516 · ownership.xml · nonDerivative · entry 3 Bolck Joachim Eberhard · CIK 0001974849 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 2,514,229 F2 · ownership.nature: Joachim and Yaeko Bolck as conservators for Yasuo Saito Bolck. Read SEC document |
| December 27, 2022 Filed Apr 25, 2023 21:49 UTC |
Bolck Joachim Eberhard10% owner
|
PurchaseCommon Stock | 10,000 | $1.02 | $10,200.00 |
DisclosureSEC source: 0001753926-23-000516 · ownership.xml · nonDerivative · entry 2 Bolck Joachim Eberhard · CIK 0001974849 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 2,514,229 F1 · ownership.nature: Joachim and Yaeko Bolck as conservators for Hideo Saito Bolck. Read SEC document |
| December 27, 2022 Filed Apr 25, 2023 21:49 UTC |
Bolck Joachim Eberhard10% owner
|
PurchaseCommon Stock | 10,000 | $1.02 | $10,200.00 |
DisclosureSEC source: 0001753926-23-000516 · ownership.xml · nonDerivative · entry 1 Bolck Joachim Eberhard · CIK 0001974849 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 548,665 Read SEC document |
| December 22, 2022 Filed Apr 25, 2023 21:47 UTC |
Bolck Joachim Eberhard10% owner
|
PurchaseCommon Stock | 10,000 | $0.92 | $9,200.00 |
DisclosureSEC source: 0001753926-23-000514 · ownership.xml · nonDerivative · entry 5 Bolck Joachim Eberhard · CIK 0001974849 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 2,504,229 F2 · ownership.nature: Joachim and Yaeko Bolck as conservators for Yasuo Saito Bolck. Read SEC document |
| December 22, 2022 Filed Apr 25, 2023 21:47 UTC |
Bolck Joachim Eberhard10% owner
|
PurchaseCommon Stock | 10,000 | $0.92 | $9,200.00 |
DisclosureSEC source: 0001753926-23-000514 · ownership.xml · nonDerivative · entry 4 Bolck Joachim Eberhard · CIK 0001974849 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 2,504,229 F1 · ownership.nature: Joachim and Yaeko Bolck as conservators for Hideo Saito Bolck. Read SEC document |
| December 21, 2022 Filed Apr 25, 2023 21:47 UTC |
Bolck Joachim Eberhard10% owner
|
PurchaseCommon Stock | 10,000 | $0.98 | $9,800.00 |
DisclosureSEC source: 0001753926-23-000514 · ownership.xml · nonDerivative · entry 3 Bolck Joachim Eberhard · CIK 0001974849 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 2,494,229 F2 · ownership.nature: Joachim and Yaeko Bolck as conservators for Yasuo Saito Bolck. Read SEC document |
| December 21, 2022 Filed Apr 25, 2023 21:47 UTC |
Bolck Joachim Eberhard10% owner
|
PurchaseCommon Stock | 10,000 | $0.98 | $9,800.00 |
DisclosureSEC source: 0001753926-23-000514 · ownership.xml · nonDerivative · entry 2 Bolck Joachim Eberhard · CIK 0001974849 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 2,494,229 F1 · ownership.nature: Joachim and Yaeko Bolck as conservators for Hideo Saito Bolck. Read SEC document |
| December 20, 2022 Filed Apr 25, 2023 21:46 UTC |
Bolck Joachim Eberhard10% owner
|
PurchaseCommon Stock | 10,000 | $0.93 | $9,300.00 |
DisclosureSEC source: 0001753926-23-000512 · ownership.xml · nonDerivative · entry 5 Bolck Joachim Eberhard · CIK 0001974849 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 2,484,229 F2 · ownership.nature: Joachim and Yaeko Bolck as conservators for Yasuo Saito Bolck. Read SEC document |
| December 20, 2022 Filed Apr 25, 2023 21:46 UTC |
Bolck Joachim Eberhard10% owner
|
PurchaseCommon Stock | 10,000 | $0.93 | $9,300.00 |
DisclosureSEC source: 0001753926-23-000512 · ownership.xml · nonDerivative · entry 4 Bolck Joachim Eberhard · CIK 0001974849 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 2,484,229 F1 · ownership.nature: Joachim and Yaeko Bolck as conservators for Hideo Saito Bolck. Read SEC document |
| December 19, 2022 Filed Apr 25, 2023 21:46 UTC |
Bolck Joachim Eberhard10% owner
|
PurchaseCommon Stock | 4,000 | $0.93 | $3,720.00 |
DisclosureSEC source: 0001753926-23-000512 · ownership.xml · nonDerivative · entry 3 Bolck Joachim Eberhard · CIK 0001974849 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 2,474,229 F2 · ownership.nature: Joachim and Yaeko Bolck as conservators for Yasuo Saito Bolck. Read SEC document |
| December 19, 2022 Filed Apr 25, 2023 21:46 UTC |
Bolck Joachim Eberhard10% owner
|
PurchaseCommon Stock | 4,000 | $0.93 | $3,720.00 |
DisclosureSEC source: 0001753926-23-000512 · ownership.xml · nonDerivative · entry 2 Bolck Joachim Eberhard · CIK 0001974849 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 2,474,229 F1 · ownership.nature: Joachim and Yaeko Bolck as conservators for Hideo Saito Bolck. Read SEC document |
| December 19, 2022 Filed Apr 25, 2023 21:46 UTC |
Bolck Joachim Eberhard10% owner
|
PurchaseCommon Stock | 1,000 | $0.93 | $930.00 |
DisclosureSEC source: 0001753926-23-000512 · ownership.xml · nonDerivative · entry 1 Bolck Joachim Eberhard · CIK 0001974849 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 538,665 Read SEC document |
| November 18, 2022 Filed Nov 21, 2022 16:11 UTC |
Dwyer DonaldChief Business Officer
|
PurchaseCommon Stock | 5,000 | $1.40 | $7,000.00 |
DisclosureSEC source: 0001753926-22-001490 · ownership.xml · nonDerivative · entry 2 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · kind: Individual purchased shares on the open market Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 16:11 UTC |
Dwyer DonaldChief Business Officer
|
PurchaseCommon Stock | 5,000 | $1.50 | $7,500.00 |
DisclosureSEC source: 0001753926-22-001490 · ownership.xml · nonDerivative · entry 1 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 F1 · kind: Individual purchased shares on the open market Read SEC document |
| November 15, 2022 Filed Apr 25, 2023 21:44 UTC |
Bolck Joachim Eberhard10% owner
|
PurchaseCommon Stock | 2,000 | $1.64 | $3,280.00 |
DisclosureSEC source: 0001753926-23-000510 · ownership.xml · nonDerivative · entry 1 Bolck Joachim Eberhard · CIK 0001974849 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 537,665 Read SEC document |
| November 07, 2022 Filed Nov 10, 2022 01:11 UTC |
Makes BrigidCFO
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001753926-22-001443 · ownership.xml · derivative · entry 1 Makes Brigid · CIK 0001375927 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2032-11-07 F1 · derivative.exercise_date: The stock options have a 10-year term and vest monthly equally over a four-year period. F2 · derivative.underlying_shares: Awarded as compensation for serving as CFO. Read SEC document |
| November 07, 2022 Filed Nov 10, 2022 01:09 UTC |
Williams GreggDirector · 10% owner
|
GrantCommon Stock Option · Derivative | 60,395 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001753926-22-001441 · ownership.xml · derivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 60,395 Underlying: Common Stock · 60,395 shares Expires 2032-11-07 F2 · derivative.exercise_date: Options vest monthly over a one-year period. F1 · balance_after: Awarded as compensation for serving on The Board of Directors and its committees. Read SEC document |
| October 21, 2022 Filed Apr 25, 2023 21:40 UTC |
Bolck Joachim Eberhard10% owner
|
PurchaseCommon Stock | 13,000 | $1.80 | $23,400.00 |
DisclosureSEC source: 0001753926-23-000508 · ownership.xml · nonDerivative · entry 3 Bolck Joachim Eberhard · CIK 0001974849 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 2,470,229 F2 · ownership.nature: Joachim and Yaeko Bolck as conservators for Yasuo Saito Bolck. Read SEC document |
| October 21, 2022 Filed Apr 25, 2023 21:40 UTC |
Bolck Joachim Eberhard10% owner
|
PurchaseCommon Stock | 13,000 | $1.80 | $23,400.00 |
DisclosureSEC source: 0001753926-23-000508 · ownership.xml · nonDerivative · entry 2 Bolck Joachim Eberhard · CIK 0001974849 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 2,470,229 F1 · ownership.nature: Joachim and Yaeko Bolck as conservators for Hideo Saito Bolck. Read SEC document |
| October 21, 2022 Filed Apr 25, 2023 21:40 UTC |
Bolck Joachim Eberhard10% owner
|
PurchaseCommon Stock | 400 | $1.80 | $720.00 |
DisclosureSEC source: 0001753926-23-000508 · ownership.xml · nonDerivative · entry 1 Bolck Joachim Eberhard · CIK 0001974849 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 535,665 Read SEC document |
| October 14, 2022 Filed Apr 25, 2023 21:39 UTC |
Bolck Joachim Eberhard10% owner
|
PurchaseCommon Stock | 6,334 | $1.76 | $11,147.84 |
DisclosureSEC source: 0001753926-23-000506 · ownership.xml · nonDerivative · entry 3 Bolck Joachim Eberhard · CIK 0001974849 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 2,457,229 F2 · ownership.nature: Joachim and Yaeko Bolck as conservators for Yasuo Saito Bolck. Read SEC document |
| October 14, 2022 Filed Apr 25, 2023 21:39 UTC |
Bolck Joachim Eberhard10% owner
|
PurchaseCommon Stock | 6,334 | $1.76 | $11,147.84 |
DisclosureSEC source: 0001753926-23-000506 · ownership.xml · nonDerivative · entry 2 Bolck Joachim Eberhard · CIK 0001974849 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 2,457,229 F1 · ownership.nature: Joachim and Yaeko Bolck as conservators for Hideo Saito Bolck. Read SEC document |
| October 14, 2022 Filed Apr 25, 2023 21:39 UTC |
Bolck Joachim Eberhard10% owner
|
PurchaseCommon Stock | 2,000 | $1.76 | $3,520.00 |
DisclosureSEC source: 0001753926-23-000506 · ownership.xml · nonDerivative · entry 1 Bolck Joachim Eberhard · CIK 0001974849 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 535,265 Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 22:57 UTC |
Popoff Alexandra L.Director
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 17,387 | $0.00 Strike: $2.80 | $0.00 |
DisclosureSEC source: 0001753926-22-001278 · ownership.xml · derivative · entry 1 Larson Alexandra L.P. · CIK 0001858534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,387 Underlying: Common Stock · 17,387 shares Expires 2032-09-14 F1 · derivative.exercise_date: The stock options have a 10-year term and vest monthly equally over three years. F2 · derivative.underlying_shares: Awarded as compensation for serving on the Board of Directors and its committees. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 22:55 UTC |
Makes BrigidCFO
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 13,584 | $0.00 Strike: $2.80 | $0.00 |
DisclosureSEC source: 0001753926-22-001276 · ownership.xml · derivative · entry 1 Makes Brigid · CIK 0001375927 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,584 Underlying: Common Stock · 13,584 shares Expires 2032-09-14 F1 · derivative.exercise_date: The stock options have a 10-year term and vest immediately. F2 · derivative.underlying_shares: Awarded as compensation for serving as CFO. Read SEC document |
| September 12, 2022 Filed Apr 25, 2023 21:37 UTC |
Bolck Joachim Eberhard10% owner
|
PurchaseCommon Stock | 10,568 | $3.15 | $33,289.20 |
DisclosureSEC source: 0001753926-23-000504 · ownership.xml · nonDerivative · entry 2 Bolck Joachim Eberhard · CIK 0001974849 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 2,450,895 F1 · ownership.nature: Joachim and Yaeko Bolck as conservators for Hideo Saito Bolck. Read SEC document |
| September 12, 2022 Filed Apr 25, 2023 21:37 UTC |
Bolck Joachim Eberhard10% owner
|
PurchaseCommon Stock | 5,000 | $3.15 | $15,750.00 |
DisclosureSEC source: 0001753926-23-000504 · ownership.xml · nonDerivative · entry 1 Bolck Joachim Eberhard · CIK 0001974849 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 533,265 Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 22:43 UTC |
Mendelsohn AdamDirector · CEO
|
OtherWarrant · Derivative | 4,585 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001196 · ownership.xml · derivative · entry 5 Mendelsohn Adam · CIK 0001940008 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,585 Underlying: Common Stock · 4,585 shares Expires 2023-12-14 F5 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision Medical, Inc., consummated on August 30, 2022 pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 22:43 UTC |
Mendelsohn AdamDirector · CEO
|
OtherWarrant · Derivative | 31,774 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001196 · ownership.xml · derivative · entry 4 Mendelsohn Adam · CIK 0001940008 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,774 Underlying: Common Stock · 31,774 shares Expires 2023-11-26 F5 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision Medical, Inc., consummated on August 30, 2022 pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 22:43 UTC |
Mendelsohn AdamDirector · CEO
|
OtherCommon Stock Option · Derivative | 60,373 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001196 · ownership.xml · derivative · entry 3 Mendelsohn Adam · CIK 0001940008 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,373 Underlying: Common Stock · 60,373 shares Expires 2028-11-13 F3 · kind: Represents the replacement option to be issued by Vivani Medical, Inc. (f/k/a Second Sight Medical Products, Inc.) at the effective time of the merger acquisition thereof, pursuant to the terms of the Agreement and Plan of Merger entered into on February 4, 2022. F4 · shares: The option vests 1/48 per month over the four years after the date of grant commencing on December 12, 2018, and the balance thereafter vests in full on the fifth anniversary of the date of grant. F4 · balance_after: The option vests 1/48 per month over the four years after the date of grant commencing on December 12, 2018, and the balance thereafter vests in full on the fifth anniversary of the date of grant. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 22:43 UTC |
Mendelsohn AdamDirector · CEO
|
OtherCommon Stock | 90,558 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-22-001196 · ownership.xml · nonDerivative · entry 2 Mendelsohn Adam · CIK 0001940008 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Trusts Disclosed balance after: 90,558 F1 · kind: Represents shares of common stock issued in the acquisition transaction of Nano Precision Medical Inc. consummated August 30, 2022. F2 · ownership.nature: Represents shares of common stock held by three trusts for the benefit of the children of the Reporting Person, over which the Reporting Person and his spouse have joint voting and diapositive authority. The Reporting Person disclaims pecuniary ownership in the shares of common stock held by the three trusts. Excludes 77,331 shares of common stock held by MFE, LLC in which the Reporting Person has a 10% ownership interest and therefore a pecuniary interest in such shares, but over which the Reporting Person does not have any voting or diapositive authority. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 22:43 UTC |
Mendelsohn AdamDirector · CEO
|
OtherCommon Stock | 3,622,015 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-22-001196 · ownership.xml · nonDerivative · entry 1 Mendelsohn Adam · CIK 0001940008 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,622,015 F1 · kind: Represents shares of common stock issued in the acquisition transaction of Nano Precision Medical Inc. consummated August 30, 2022. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 19:43 UTC |
Baker Wilford DeanDirector
|
OtherCommon Stock Option · Derivative | 30,187 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001202 · ownership.xml · derivative · entry 4 Baker Wilford Dean · CIK 0001377879 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,187 Underlying: Common Stock · 30,187 shares Expires 2030-11-09 F2 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision Medical, Inc., consummated on August 30, 2022 pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 19:43 UTC |
Baker Wilford DeanDirector
|
OtherCommon Stock Option · Derivative | 30,187 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001202 · ownership.xml · derivative · entry 3 Baker Wilford Dean · CIK 0001377879 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,187 Underlying: Common Stock · 30,187 shares Expires 2029-11-11 F2 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision Medical, Inc., consummated on August 30, 2022 pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 19:43 UTC |
Baker Wilford DeanDirector
|
OtherCommon Stock Option · Derivative | 30,187 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001202 · ownership.xml · derivative · entry 2 Baker Wilford Dean · CIK 0001377879 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,187 Underlying: Common Stock · 30,187 shares Expires 2028-11-13 F2 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision Medical, Inc., consummated on August 30, 2022 pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 19:43 UTC |
Baker Wilford DeanDirector
|
OtherCommon Stock | 197,482 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-22-001202 · ownership.xml · nonDerivative · entry 1 Baker Wilford Dean · CIK 0001377879 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,482 F1 · kind: Represents shares of common stock issued in the acquisition transaction of Nano Precision Medical Inc. consummated August 30, 2022. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 23:41 UTC |
Mendelsohn AaronDirector
|
OtherWarrants · Derivative | 25,927 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001200 · ownership.xml · derivative · entry 7 Mendelsohn Aaron · CIK 0001625195 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 25,927 Underlying: Common Stock · 25,927 shares Expires 2023-12-14 F5 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision medical, Inc., consummated on August 30, 2022, pursuant to the Agreement and Plan of Merger dated February 4, 2022. F6 · ownership.nature: Represents shares of common stock underlying a warrant owned by MFE, LLC over which the Reporting Person has voting and dispositive authority. The Reporting Person disclaims pecuniary interest in 20% of the limited liability company and therefore 5,185 shares of common stock held by the limited liability company, which are beneficially owned by other members of the limited liability company. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 23:41 UTC |
Mendelsohn AaronDirector
|
OtherCommon Stock Option · Derivative | 30,187 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001200 · ownership.xml · derivative · entry 6 Mendelsohn Aaron · CIK 0001625195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,187 Underlying: Common Stock · 30,187 shares Expires 2030-11-19 F4 · kind: Represents the replacement option to be issued by Vivian Medical, Inc. (f/k/a Second Sight Medical Products, Inc.) at the effective time of the merger acquisition thereof, pursuant to the terms of the Agreement and Plan of Merger entered into on February 4, 2022. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 23:41 UTC |
Mendelsohn AaronDirector
|
OtherCommon Stock Option · Derivative | 30,187 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001200 · ownership.xml · derivative · entry 5 Mendelsohn Aaron · CIK 0001625195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,187 Underlying: Common Stock · 30,187 shares Expires 2029-11-11 F4 · kind: Represents the replacement option to be issued by Vivian Medical, Inc. (f/k/a Second Sight Medical Products, Inc.) at the effective time of the merger acquisition thereof, pursuant to the terms of the Agreement and Plan of Merger entered into on February 4, 2022. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 23:41 UTC |
Mendelsohn AaronDirector
|
OtherCommon Stock Option · Derivative | 30,187 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001200 · ownership.xml · derivative · entry 4 Mendelsohn Aaron · CIK 0001625195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,187 Underlying: Common Stock · 30,187 shares Expires 2028-11-13 F4 · kind: Represents the replacement option to be issued by Vivian Medical, Inc. (f/k/a Second Sight Medical Products, Inc.) at the effective time of the merger acquisition thereof, pursuant to the terms of the Agreement and Plan of Merger entered into on February 4, 2022. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 23:41 UTC |
Mendelsohn AaronDirector
|
OtherCommon Stock | 747,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-22-001200 · ownership.xml · nonDerivative · entry 3 Mendelsohn Aaron · CIK 0001625195 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 747,387 F1 · kind: Represents shares of common stock issued in the acquisition transaction of Nano Precision Medical Inc. consummated August 30, 2022. F3 · ownership.nature: Represents shares of common stock owned by MFE, LLC over which the Reporting Person has voting and dispositive authority. The Reporting Person disclaims pecuniary interest in 20% of the limited liability company and therefore 149,478 shares of common stock held by the limited liability company, which are beneficially owned by other members of the limited liability company. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 23:41 UTC |
Mendelsohn AaronDirector
|
OtherCommon Stock | 150,930 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-22-001200 · ownership.xml · nonDerivative · entry 2 Mendelsohn Aaron · CIK 0001625195 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trusts Disclosed balance after: 150,930 F1 · kind: Represents shares of common stock issued in the acquisition transaction of Nano Precision Medical Inc. consummated August 30, 2022. F2 · ownership.nature: Represents five trusts, each one established for a separate grandchild of the Reporting Person, each trust owning an aggregate of 30,186 shares of common stock, all trusts with the same terms, over which the Reporting Person has voting and dispositive authority. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 23:41 UTC |
Mendelsohn AaronDirector
|
OtherCommon Stock | 178,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-22-001200 · ownership.xml · nonDerivative · entry 1 Mendelsohn Aaron · CIK 0001625195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,170 F1 · kind: Represents shares of common stock issued in the acquisition transaction of Nano Precision Medical Inc. consummated August 30, 2022. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 22:39 UTC |
Le TrucCOO
|
OtherCommon Stock Option · Derivative | 150,933 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001192 · ownership.xml · derivative · entry 2 Le Truc · CIK 0001940176 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,933 Underlying: Common Stock · 150,933 shares Expires 2031-03-07 F1 · kind: Represents the replacement option to be issued by Vivani Medical, Inc. (f/k/a Second Sight Medical Products, Inc.) at the effective time of the merger acquisition thereof, pursuant to the terms of the Agreement and Plan of Merger entered into on February 4, 2022. F3 · shares: The option vests 1/48 per month over the four years after the date of grant commencing on March 7, 2021, and the balance thereafter vests in full on the fifth anniversary of the date of grant. F3 · balance_after: The option vests 1/48 per month over the four years after the date of grant commencing on March 7, 2021, and the balance thereafter vests in full on the fifth anniversary of the date of grant. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 22:39 UTC |
Le TrucCOO
|
OtherCommon Stock Option · Derivative | 603,732 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001192 · ownership.xml · derivative · entry 1 Le Truc · CIK 0001940176 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 603,732 Underlying: Common Stock · 603,732 shares Expires 2030-07-30 F1 · kind: Represents the replacement option to be issued by Vivani Medical, Inc. (f/k/a Second Sight Medical Products, Inc.) at the effective time of the merger acquisition thereof, pursuant to the terms of the Agreement and Plan of Merger entered into on February 4, 2022. F2 · shares: The option vested as to 301,866 shares on February 28, 2021 and 150,933 shares on July 16, 2021 and after July 16, 2021 the balance of the shares vested and will vest at the rate of 4312.367 shares per month for 35 months. F2 · balance_after: The option vested as to 301,866 shares on February 28, 2021 and 150,933 shares on July 16, 2021 and after July 16, 2021 the balance of the shares vested and will vest at the rate of 4312.367 shares per month for 35 months. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 22:24 UTC |
Dwyer DonaldChief Business Officer
|
OtherCommon Stock Option · Derivative | 36,224 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001184 · ownership.xml · derivative · entry 3 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,224 Underlying: Common Stock · 36,224 shares Expires 2031-02-27 F1 · kind: Represents the replacement option to be issued by Vivani Medical, Inc. (f/k/a Second Sight Medical Products, Inc.) at the effective time of the merger acquisition thereof, pursuant to the terms of the Agreement and Plan of Merger entered into on February 4, 2022. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 22:24 UTC |
Dwyer DonaldChief Business Officer
|
OtherCommon Stock Option · Derivative | 217,344 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001184 · ownership.xml · derivative · entry 2 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,344 Underlying: Common Stock · 217,344 shares Expires 2030-11-09 F1 · kind: Represents the replacement option to be issued by Vivani Medical, Inc. (f/k/a Second Sight Medical Products, Inc.) at the effective time of the merger acquisition thereof, pursuant to the terms of the Agreement and Plan of Merger entered into on February 4, 2022. F2 · shares: The option vests monthly in equal parts over the three years after the date of grant commencing November 1, 2020. F2 · balance_after: The option vests monthly in equal parts over the three years after the date of grant commencing November 1, 2020. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 22:24 UTC |
Dwyer DonaldChief Business Officer
|
OtherCommon Stock Option · Derivative | 36,224 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001184 · ownership.xml · derivative · entry 1 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,224 Underlying: Common Stock · 36,224 shares Expires 2029-11-11 F1 · kind: Represents the replacement option to be issued by Vivani Medical, Inc. (f/k/a Second Sight Medical Products, Inc.) at the effective time of the merger acquisition thereof, pursuant to the terms of the Agreement and Plan of Merger entered into on February 4, 2022. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 22:20 UTC |
Porter Lisa EllenChief Medical Officer
|
OtherCommon Stock Option · Derivative | 241,493 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001180 · ownership.xml · derivative · entry 1 Porter Lisa Ellen · CIK 0001940462 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,493 Underlying: Common Stock · 241,493 shares Expires 2030-04-07 F1 · kind: Represents the replacement option to be issued by Vivani Medical, Inc. (f/k/a Second Sight Medical Products, Inc.) at the effective time of the merger acquisition thereof, pursuant to the terms of the Agreement and Plan of Merger entered into on February 4, 2022. F2 · shares: The option vests 1/48 per month over the four years after the date of grant commencing on January 6, 2020, and the balance thereafter vests in full on the fifth anniversary of the date of grant. F2 · balance_after: The option vests 1/48 per month over the four years after the date of grant commencing on January 6, 2020, and the balance thereafter vests in full on the fifth anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.